{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:33:55Z","timestamp":1774492435155,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neo.2014.03.011","type":"journal-article","created":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T02:49:34Z","timestamp":1400899774000},"page":"291-300","source":"Crossref","is-referenced-by-count":20,"title":["Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin \u03b15\u2013 and Integrin \u03b23\u2013Dependent Mechanism"],"prefix":"10.1016","volume":"16","author":[{"given":"Eva","family":"Juengel","sequence":"first","affiliation":[]},{"given":"Jasmina","family":"Makarevi\u0107","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Reiter","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Mani","sequence":"additional","affiliation":[]},{"given":"Igor","family":"Tsaur","sequence":"additional","affiliation":[]},{"given":"Georg","family":"Bartsch","sequence":"additional","affiliation":[]},{"given":"Axel","family":"Haferkamp","sequence":"additional","affiliation":[]},{"given":"Roman A.","family":"Blaheta","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2014.03.011_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1758834012443725","article-title":"Novel agents in renal carcinoma: a reality check","volume":"4","author":"Najjar","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.neo.2014.03.011_bb0010","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1002\/cncr.27668","article-title":"Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy","volume":"118","author":"Cho","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2014.03.011_bb0015","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/cncr.22677","article-title":"Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy","volume":"109","author":"Pantuck","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.neo.2014.03.011_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2011-S2-14","article-title":"Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence","volume":"16","author":"Hutson","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.neo.2014.03.011_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/157488411797189389","article-title":"Looking beyond inhibition of VEGF\/mTOR: emerging targets for renal cell carcinoma drug development","volume":"6","author":"Rasmussen","year":"2011","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.neo.2014.03.011_bb0030","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/bjc.2013.602","article-title":"Acquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2","volume":"109","author":"Harada","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2014.03.011_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.05.003","article-title":"Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells","volume":"324","author":"Juengel","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2014.03.011_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2011.08.026","article-title":"The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line","volume":"313","author":"Tsaur","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2014.03.011_bb0045","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1158\/0008-5472.CAN-13-0602","article-title":"Integrin \u03b1v\u03b23 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis","volume":"73","author":"Knowles","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.03.011_bb0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/bjc.2012.313","article-title":"Resistance to the mTOR-inhibitor RAD001 elevates integrin \u03b12- and \u03b21-triggered motility, migration and invasion of prostate cancer cells","volume":"107","author":"Tsaur","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2014.03.011_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","article-title":"Initial steps of metastasis: cell invasion and endothelial transmigration","volume":"728","author":"van Zijl","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.neo.2014.03.011_bb0060","first-page":"1145","article-title":"Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail","volume":"36","author":"Messai","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.neo.2014.03.011_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/1541-7786.MCR-10-0139","article-title":"Mechanisms of motility in metastasizing cells","volume":"8","author":"Yilmaz","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.neo.2014.03.011_bb0070","first-page":"5587","article-title":"Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin","volume":"61","author":"Isogai","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2014.03.011_bb0075","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1582-4934.2007.00071.x","article-title":"Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes","volume":"11","author":"Jones","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.neo.2014.03.011_bb0080","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1016\/j.yexcr.2007.07.001","article-title":"CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells","volume":"313","author":"Jones","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neo.2014.03.011_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ijc.20778","article-title":"Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves \u03b1v integrins and the participation of MMP2","volume":"114","author":"Leroy-Dudal","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2014.03.011_bb0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2174\/138161209787846720","article-title":"Cellular receptors of extracellular matrix molecules","volume":"15","author":"Heino","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neo.2014.03.011_bb0095","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s11033-011-1065-y","article-title":"Down-regulation of \u03b23-integrin inhibits bone metastasis of small cell lung cancer","volume":"39","author":"Li","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.neo.2014.03.011_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/ncb2491","article-title":"MYC suppresses cancer metastasis by direct transcriptional silencing of \u03b1v and \u03b23 integrin subunits","volume":"14","author":"Liu","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neo.2014.03.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.005397","article-title":"Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells","volume":"10","author":"Lei","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.neo.2014.03.011_bb0110","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1242\/jcs.101444","article-title":"The metastasis gene NEDD9 product acts through integrin \u03b23 and Src to promote mesenchymal motility and inhibit amoeboid motility","volume":"125","author":"Ahn","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neo.2014.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/ijc.22879","article-title":"Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for \u03b1v\u03b23 integrin","volume":"121","author":"Bauer","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2014.03.011_bb0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ceb.2013.05.008","article-title":"Role of adhesion receptor trafficking in 3D cell migration","volume":"25","author":"Jacquemet","year":"2013","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.neo.2014.03.011_bb0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1083\/jcb.200703185","article-title":"A molecular switch that controls cell spreading and retraction","volume":"179","author":"Flevaris","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neo.2014.03.011_bb0130","doi-asserted-by":"crossref","first-page":"e55980","DOI":"10.1371\/journal.pone.0055980","article-title":"Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling","volume":"8","author":"Jeruschke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2014.03.011_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/CBI20110069","article-title":"Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells","volume":"36","author":"Goundiam","year":"2012","journal-title":"Cell Biol Int"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861400030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861400030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T23:25:57Z","timestamp":1538609157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655861400030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S147655861400030X"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2014.03.011","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}